Frequency of Human Immunodeficiency Virus Infection in patients at the Hospital National during the period 2021-2023
Article Sidebar
Main Article Content
Abstract
Introduction: the human immunodeficiency virus continues to be one of the main public health problems worldwide and is a major cause of death. The generalization of HIV testing in the population is a public health strategy.
Objective: to determine the frequency of HIV infection in patients who presented to the emergency department from March 2021 to October 2023. Methodology: this was an observational, descriptive study; adult patients admitted to the emergency department from March 2021 to October 2023 were included. For the calculation of the sample we used an expected proportion of 0.1 (1 %) and an amplitude of 0.10 (precision), confidence level of 95 %, which yielded a size of 974 patients. The data were processed in the EPI Info statistical package (Atlanta-CDC).
Results: 976 patients were included in the study, the frequency of human immunodeficiency virus seropositivity by ELISA test was 12.8 % (n = 126), the average age of the positive patients was 38.4 ± 13 years old, regarding risk factors, 18.25 % (n = 23) reported illicit drug use; 16.66 % (n = 21) tattoos; 11.90 % (n = 15) history of blood product transfusions; 7.14 % (n = 9) piercings.
Conclusion: the frequency of HIV seropositivity by ELISA test was 12.8% in adult patients who come to the emergency room for any reason.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Organización Mundial de la Salud. VIH y SIDA. 2023. Ginebra: OMS. Disponible en https://www.who.int/es/news-room/fact-sheets/detail/hiv-aids
Paraguay. Ministerio de Salud Pública y Bienestar Social. Programa Nacional del control VIH/SIDA/ITS. Situación epidemiológica del VIH. 2022. Asunción: El Ministerio. Disponible en: https://www.mspbs.gov.py/dependencias/pronasida/adjunto/252034-INFORMEEPIDEMIOLOGICOVIH2022.pdf
Portillo P, Del Arco Galán A, De C, Gil S, Salvanés F Negro Rua IR, Ubago MDR. Prevalencia y características de los pacientes con infección por virus de la inmunodeficiencia humana (VIH) diagnosticados de novo en un servicio de urgencias. Emergencias. 2016;28:313–9.
Bassett IV, Walensky RP. Integrating HIV screening into routine health care in resource-limited settings. Clin Infect Dis. 2010;50 (Suool 3):S77-84. doi: 10.1086/651477
Cortés Moneada C. OMS y ONU-SIDA llaman a controlar la epidemia de infección por VIH/SIDA. Rev Chilena Infectol [Internet]. 2015;32(6):711–711. doi: 10.4067/s0716-10182015000700017
Reyes Urueña J, Fernández López L, Force L, Daza M, Agustí C, Casabona, J. Estudio del impacto a nivel de salud pública del cribado universal del virus de la inmunodeficiencia humana en un servicio de Urgencias. Enferm. infecc. microbiol. clín. 2017;35(7): 434-437.
Pizarro A, del Arco Galán C, de los Santos Gil I, Rodríguez Salvanés F, Negro Rua M, del Rey Ubago A. Prevalencia y características de los pacientes con infección por virus de la inmunodeficiencia humana (VIH) diagnosticados de novo en un servicio de urgencias Emergencias. 2016;28(5):313-319
España. Ministerio de Sanidad. Vigilancia Epidemiolóigca del VIH y SIDA en España 2021. 2022. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Documents/VIH/informes%20de%20vigilancia%20VIH%20y%20sida%20anteriores/Informe%20VIH_SIDA_2022_CCAA.pdf
Grupo para el Estudio Anónimo no Relacionado de Seroprevalencia de virus de la immunodeficiencia humana en consultas de ETS: HIV seroprevalence among patients attending sexually transmitted clinics in Spain, 1998-2000. Med Clin (Barc). 2002;119(7):249-51.
Marks G, Crepaz N, Janssen RS. Estimating sexual transmission of HIV from persons aware and unaware that they are infected with the virus in the USA. AIDS [Internet]. 2006;20(10):1447–50. doi: 0.1097/01.aids.0000233579.79714.8d
Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55(RR-14): 1-17
Burns F, Edwards SG, Woods J, Haidari G, Calderon Y, Leider J, et al. Acceptability, feasibility and costs of universal offer of rapid point of care testing for HIV in an acute admissions unit: results of the RAPID project. HIV Med. 2013;14(Suppl 3): 10-14. doi: 10.1111/hiv.12056.
European Centre for Disease. Prevention and control HIV testing: Increasing uptake and effectiveness in the European Union. ECDC. 2010 [consultado 11 Feb 2015]. Disponible: http://ecdc.europa.eu/en/publications/Publications/101129_GUI_HIV_testing.pdf
Dowdy DW, Rodriguez RM, Hare CB, Kaplan B. Cost-effectiveness of targeted human immunodeficiency virus screening in an urban emergency department. Acad Emerg Med. 2011;18(7):745-753. doi: 10.1111/j.1553-2712.2011.01110.x.
Y. Yazdanpanah, C.E. Sloan, C. Charlois-Ou, S. Le Vu, C. Semaille, D. Costagliola, et al. Routine HIV screening in France: clinical impact and cost-effectiveness. PLoS One. 2010;5(10):e13132. doi: 10.1371/journal.pone.0013132.